Utilization of accelerated partial breast irradiation for ductal carcinoma in situ, 2003–2011: Report from the national cancer database

Annals of Surgical Oncology

Volumn 21, Issue 11, 2014, Pages 3457-3465

  Yao, Katharine ^a   Czechura, Tomasz ^a   Liederbach, Erik ^a   Winchester, David J ^a   Pesce, Catherine ^a   Shaikh, Arif ^a   Winchester, David P ^a   Huo, Dezheng ^b  

^a NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCELERATED PARTIAL BREAST IRRADIATION; ADULT; AGED; ARTICLE; BRACHYTHERAPY; COMMUNITY; DATA BASE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HEALTH CARE FACILITY; HEALTH PROGRAM; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; MIDDLE AGED; ONCOLOGY; PARTIAL MASTECTOMY; PRACTICE GUIDELINE; UNITED STATES; UNIVERSITY HOSPITAL; VERY ELDERLY; YOUNG ADULT; BREAST NEOPLASMS; CANCER GRADING; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; FACTUAL DATABASE; FOLLOW UP; PATHOLOGY; PROGNOSIS; RADIATION DOSE; UTILIZATION;

ADULT; AGED; AGED, 80 AND OVER; BRACHYTHERAPY; BREAST NEOPLASMS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, INTRADUCTAL, NONINFILTRATING; CARCINOMA, LOBULAR; DATABASES, FACTUAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; NEOPLASM GRADING; PROGNOSIS; RADIOTHERAPY DOSAGE;

EID: 84922583997     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-014-3717-3     Document Type: Article

References (26)

1. Hattangadi J, Taback N, Neville BA, et al. Accelerated partial breast irradiation using brachytherapy for breast cancer: patterns in utilization and guideline concordance. J Natl Cancer Inst. 2012;104:29–41.
2. Smith GL, Xu Y, Buchholz TA, et al. Brachytherapy for accelerated partial breast irradiation: a rapidly emerging technology in breast cancer care. J Clin Oncol. 2011;29:157–165.
3. Czechura T, Winchester DJ, Pesce C, Huo D, Winchester DP, Yao K. Accelerated partial-breast irradiation versus whole-breast irradiation for early-stage breast cancer patients undergoing breast conservation, 2003-2010: a report from the National Cancer Data Base. Ann Surg Oncol. 2013;20:3223–3232.
4. Abbott AM, Habermann EB, Tuttle TM. Trends in the use of implantable accelerated partial breast irradiation therapy for early stage breast cancer in the United States. Cancer. 2011;117: 3305–3310.
5. Bilimoria KY, Stewart AK, Winchester DP, et al. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15:683–690.
6. Smith BD, Arthur DW, Buchholz TA, et al. Accelerated partial breast irradiation consensus statement from the American Society For Radiation Oncology (ASTRO). Int J Radiat Oncol Biol Phys. 2009;74:987-1001.
7. Census Regions and Divisions of the United States. 2010.
8. Jeruss JS, Vicini FA, Beitsch PD, et al. Initial outcomes for patients treated on the American Society of Breast Surgeons MammoSite clinical trial for ductal carcinoma-in situ of the breast. Ann Surg Oncol. 2006;13:967-976.
9. Vicini F, Beitsch PD, Quiet CA, et al. Three-year analysis of treatment efficacy, cosmesis, and toxicity by the American Society of Breast Surgeons MammoSite Breast Brachytherapy Registry Trial in patients treated with accelerated partial breast irradiation (APBI). Cancer. 2008;112:758-766.
10. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys. 2003;55:289-293.
11. Benitez PR, Streeter O, Vicini F, et al. Preliminary results and evaluation of MammoSite balloon brachytherapy for partial breast irradiation for pure ductal carcinoma in situ: a phase II clinical study. Am J Surg. 2006;192:427–433.
12. Smith GL, Xu Y, Buccholz TA, et al. Association between treatment with brachytherapy vs. whole-breast irradiation and subsequent mastectomy, complications, and survival among older women with invasive breast cancer. JAMA. 2012;307:1827-1837.
13. Presley CJ, Soulos PR, Herrin J, et al. Patterns of use and short-term complications of breast brachytherapy in the national medicare population from 2008-2009. J Clin Oncol. 2012; 30:4302–4307.
14. Wong JS, Kaelin CM, Troyan SL, et al. Prospective study of wide excision alone for ductal carcinoma in situ of the breast. J Clin Oncol. 2006;24:1031-1036.
15. Holmberg L, Garmo H, Granstrand B, et al. Absolute risk reduction for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breast. J Clin Oncol. 2008;26:1247-1252.
16. Hughes LL, Wang M, Page DL, et al. Local excision alone without irradiation for ductal carcinoma in situ of the breast: a trial of the Eastern Cooperative Oncology Group. J Clin Oncol. 2009;27:5319-5324.
17. Smith BD, Pan IW, Shih YC, Smith GL, et al. Adoption of intensity modulated radiaton therapy for breast cancer in the United States. J Natl Cancer Inst. 2011;103:798-809.
18. Suh WW, Pierce LJ, Vicini FA, et al. A cost comparison analysis of partial versus whole-breast irradiation after breast conserving surgery for early stage breast cancer. Int J Radiat Oncol Biol Phys. 2005;62:790-796.
19. Malin JL, Kahn KL, Adams J, et al. Validity of cancer registry data for measuring the quality of breast cancer care. J Natl Cancer Inst. 2002;94:835-844.
20. Du X, Freeman JL, Goodwin JS. Information on radiation treatment in patients with breast cancer: the advantages of the linked medicare and SEER data. Surveillance, Epidemiology, and End Results. J Clin Epidemiol. 1999;52:463–470.
21. Shah C, Badiyan S, Wilkinson JB, et al. Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy registry trial. Ann Surg Oncol. 2013;20: 3279-3285.
22. Vicini F, Shah C, Wilkinson JB, et al. Should ductal carcinoma-in situ (DCIS) be removed from the ASTRO consensus panel cautionary group for off-protocol use of accelerated partial breast irradiation (APBI)? A pooled analysis of outcomes for 300 patients with DCIS treated with APBI. Ann Surg Oncol. 2013; 20:1275-1281.
23. McHaffie DR, Patel RR, Adkison JB, et al. Outcomes after accelerated partial breast irradiation in patients with ASTRO consensus statement cautionary features. Int J Radiat Oncol Biol Phys. 2011;81:46–51.
24. Stull TS, Goodwin MC, Gracely EJ, et al. A single-institution review of accelerated partial breast irradiation in patients considered ‘‘cautionary’’ by the American Society for Radiation Oncology. Ann Surg Oncol. 2012;19:553–559.
25. Abbott AM, Portschy PR, Lee C, et al. Prospective multicenter trial evaluating balloon-catheter partial-breast irradiation forductal carcinoma in situ. Int J Radiat Oncol Biol Phys. 2013;87:494–498.
26. Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 2010;103:478–488.